Legal & General Group
XGN icon

Legal & General Group’s Exagen XGN Stock Holding History

Legal & General Group’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-907
Closed -$7K – 3673
2022
Q1 		$7K Hold
907
– – ﹤0.01% 3473
2021
Q4 		$11K Hold
907
– – ﹤0.01% 3446
2021
Q3 		$12K Sell
907
-87
-9% -$1.16K ﹤0.01% 3422
2021
Q2 		$15K Buy
994
+451
+83% +$6.92K ﹤0.01% 3381
2021
Q1 		$10K Sell
543
-39
-7% -$695 ﹤0.01% 3388
2020
Q4 		$8K Hold
582
– – ﹤0.01% 3397
2020
Q3 		$6K Sell
582
-240
-29% -$3.09K ﹤0.01% 3367
2020
Q2 		$10K Buy
822
+401
+95% +$5.43K ﹤0.01% 3315
2020
Q1 		$6K Sell
421
-289
-41% -$5.74K ﹤0.01% 3248
2019
Q4 		$18K Buy
+710
New +$12.6K ﹤0.01% 3214

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Legal & General Group's XGN Position: Q2 2022 in Review

Legal & General Group sold out of Exagen (XGN) in Q2 2022, closing a stake of 907 shares — an estimated $7K sold.

Legal & General Group first reported a position in XGN in Q4 2019 and held it in 10 quarters. The position peaked at $18K in Q4 2019. 47 funds tracked by Wall St. Rank hold XGN as of Q2 2022.

  • Legal & General Group reported no remaining Exagen position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 907 Exagen shares in Q2 2022, an estimated $7K.
  • Legal & General Group first reported a position in Exagen in Q4 2019 and held it in 10 quarters.
  • Legal & General Group's Exagen position peaked at $18K in Q4 2019.
  • 47 funds tracked by Wall St. Rank held Exagen as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.